Full Name
Chi Lui Paul Ho
Variants
Ho, P.
Ho, P.C
Ho P.C
Ho, P.C.L.
Ho, P.C.
Ho, P.C.-L.
 
Main Affiliation
 
Faculty
 
Email
phahocl@nus.edu.sg
 

Publications

Results 121-140 of 156 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
121Dec-2010Quantification of oxyresveratrol analog trans-2,4,3',5'-tetramethoxystilbene in rat plasma by a rapid HPLC method: Application in a pre-clinical pharmacokinetic studyLin, H.-S. ; Choo, Q.-Y.; Ho, P.C. 
25-Jul-2013Quantification of pinosylvin in rat plasma by liquid chromatography-tandem mass spectrometry: Application to a pre-clinical pharmacokinetic studyYeo, S.C.M.; Luo, W.; Wu, J.; Ho, P.C. ; Lin, H.-S. 
323-Feb-2011Quantification of trans -3,4,5,4′-tetramethoxystilbene in rat plasma by HPLC: Application to pharmacokinetic studyLin, H.-S. ; Zhang, W.; Go, M.L. ; Tringali, C.; Spatafora, C.; Ho, P.C. 
418-Jan-2013Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: Application to a pharmacokinetic studyLin, H.-S. ; Sviripa, V.M.; Watt, D.S.; Liu, C.; Xiang, T.-X.; Anderson, B.D.; Ong, P.S. ; Ho, P.C. 
526-Feb-2003Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assayWang, L.Z. ; Ho, P.C. ; Lee, H.S.; Vaddi, H.K.; Chan, Y.W.; Yung, C.S. 
615-Jul-2011Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Lim, M.Y.-X.; Chin, T.-M. ; Thuya, W.-L. ; Nye, P.-L.; Wong, A.; Chan, S.-Y. ; Goh, B.-C.; Ho, P.C. 
731-Dec-2021Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?Ma, Z; Woon, CYN; Liu, CG; Cheng, JT; You, M; Sethi, G ; Wong, ALA ; Ho, PCL ; Zhang, D; Ong, P; Wang, L ; Goh, BC 
81-Sep-2021Resveratrol for cancer therapy: Challenges and future perspectivesRen, Boxu; Kwah, Marabeth Xin-Yi; Liu, Cuiliu; Ma, Zhaowu; Shanmugam, Muthu K. ; Ding, Lingwen ; Xiang, Xiaoqiang; Ho, Paul Chi-Lui ; Wang, Lingzhi ; Ong, Pei Shi ; Goh, Boon Cher 
9Aug-2007Reversible effects of permeation enhancers on human skinKang, L. ; Poh, A.L.; Fan, S.K. ; Ho, P.C. ; Chan, Y.W.; Chan, S.Y. 
1022-Nov-2010Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activitiesWang, Z.; Ho, P.C. 
11Oct-2010Solubilization of vorinostat by cyclodextrinsCai, Y.Y.; Yap, C.W. ; Wang, Z.; Ho, P.C. ; Chan, S.Y. ; Ng, K.Y. ; Ge, Z.G.; Lin, H.S. 
1213-Feb-2004Speciation of inorganic and methylated arsenic compounds by capillary zone electrophoresis with indirect UV detection - Application to the analysis of alkali extracts of As2S2 (realgar) and As 2S3 (orpiment)Wu, J.-Z.; Ho, P.C. 
13Jun-2005St. John's wort modulates the toxicities and pharmacokinetics of CPT-11 (Irinotecan) in ratsHu, Z.; Yang, X.; Ho, P.C.-L. ; Chan, E. ; Sui, Y.C. ; Xu, C.; Li, X.; Zhu, Y.-Z.; Duan, W.; Chen, X.; Huang, M.; Yang, H.; Zhou, S. 
141997Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chlorideHor, M.M.S.; Chan, S.Y. ; Yow, K.L.; Lim, L.Y. ; Chan, E. ; Ho, P.C. 
151998Stability of captopril in invert sugar solutionSam, W.J.; Ho, P.C. 
161998Stability of cefazolin sodium eye dropsHow, T.H.; Loo, W.Y.; Yow, K.L.; Lim, L.Y. ; Chan, E.W. ; Ho, P.C. ; Chan, S.Y. 
172001Stability of extemporaneously prepared gentamicin ophthalmic solutions [4]Ho, P.C. ; Soh, H.; Lim, S.M.
18Dec-2003Stability of extemporaneously prepared saquinavir formulationsTan, L.K.; Thenmozhiyal, J.C. ; Ho, P.C. 
191997Stability of morphine sulphate in saline under simulated patient administration conditionsHor, M.M.S.; Chan, S.Y. ; Yow, K.L.; Lim, L.Y. ; Chan, E. ; Ho, P.C. 
2015-Sep-1997Stability of phenoxybenzamine hydrochloride in various vehiclesLim, L.-Y. ; Tan, L.-L.; Chan, E.W.Y. ; Yow, K.-L.; Chan, S.-Y. ; Ho, P.C.L.